Answer
Nimenrix induces bactericidal antibodies against capsular polysaccharides of Neisseria meningitidis groups A, C, W-135 and Y, which protect through complement-mediated bacterial killing.
Sources for this answer
- Nimenrix powder and solvent for solution for injection in pre-filled syringePfizer Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 34Document updated
Sources checked